Ontology highlight
ABSTRACT: Background
Interleukin-6 receptor antagonists (IL-6RAs) and steroids are emerging immunomodulatory therapies for severe and critical coronavirus disease (COVID-19). In this preliminary report, we aim to describe the epidemiology, clinical characteristics, and outcomes of adult critically ill COVID-19 patients, requiring invasive mechanical ventilation (iMV), and receiving IL-6RA and steroids therapy over the last 11 months.Materials and methods
International, multicenter, cohort study derived from Viral Infection and Respiratory Illness University Study registry and conducted through Discovery Network, Society of Critical Care Medicine. Data were collected between March 01, 2020, and January 10, 2021.Results
Of 860 patients who met eligibility criteria, 589 received
SUBMITTER: Amer M
PROVIDER: S-EPMC8487342 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature